Other
Neoplasm by Morphology
CI-CAN-00000002Explore in graph →
Non-malignant13,319 active trials222 approved drugs2,774 evidence items
- NCIt
- C4741
Loading cancer entity…
Loading cancer entity…
Other
CI-CAN-00000002Explore in graph →
Clinical trials
52,657 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03659669 | A Study to Describe the Effectiveness and Safety of Venetoclax Treatment in Chronic Lymphocytic Leukemia (CLL) Patients in Routine Clinical Practice(REVEAL) | suspended | — | 272 | AbbVieINDUSTRY | 1 | Oct 23, 2023 | clinicaltrials |
| NCT04485052 | Efficacy and Safety Evaluation of IBI188 in Combination With Demethylating Agents in Treatment of Patients With Acute Myeloid Leukemia | suspended | Phase 1 / Phase 2 | 222 | Innovent Biologics (Suzhou) Co. Ltd.INDUSTRY |
| 1 |
| Oct 23, 2023 |
| clinicaltrials |
| NCT04427306 | Neoadjuvant T-VEC in High Risk Early Melanoma | suspended | Phase 2 | 6 | University of California, DavisOTHER | 1 | Sep 15, 2023 | clinicaltrials |
| NCT01796795 | Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients | suspended | Phase 2 | 102 | G&E Herbal Biotechnology Co., LTDINDUSTRY | 0 | Sep 14, 2023 | clinicaltrials |
| NCT03229876 | Safety and Efficacy Evaluation of CD19-UCART | suspended | N/A | 20 | Bioray LaboratoriesINDUSTRY | 1 | Jul 24, 2023 | clinicaltrials |
| NCT03055208 | Early Stereotactic Gamma Knife Radiosurgery to Residual Tumor After Surgery of Newly Diagnosed Glioblastoma(Gamma-GBM) | suspended | N/A | 50 | Universitätsmedizin MannheimOTHER | 1 | May 11, 2023 | clinicaltrials |
| NCT03002103 | A Trial Evaluating the Efficacy and Safety of EndoTAG®-1 in Combination With Paclitaxel and Gemcitabine Compared With Paclitaxel and Gemcitabine as First-line Therapy in Patients With Visceral Metastatic Triple-negative Breast Cancer | suspended | Phase 3 | 420 | SynCore Biotechnology Co., Ltd.INDUSTRY | 1 | Apr 26, 2023 | clinicaltrials |
| NCT04650451 | Safety and Activity Study of HER2-Targeted Dual Switch CAR-T Cells (BPX-603) in Subjects With HER2-Positive Solid Tumors | suspended | Phase 1 | 220 | Bellicum PharmaceuticalsINDUSTRY | 1 | Apr 20, 2023 | clinicaltrials |
| NCT01933815 | Dose-Escalation Study of TPI 287 + Avastin Followed by Randomized Study of the Same Versus Avastin for Glioblastoma | suspended | Phase 1 / Phase 2 | 92 | Cortice Biosciences, Inc.INDUSTRY | 1 | Feb 22, 2023 | clinicaltrials |
| NCT04746131 | Safety and Pharmacokinetic Study of IMM0306 in Patients With Refractory or Relapsed CD20-positive B-cell Non-Hodgkin's Lymphoma (B-NHL) | suspended | Phase 1 | 90 | ImmuneOnco Biopharmaceuticals (Shanghai) Inc.OTHER | 1 | Sep 26, 2022 | clinicaltrials |
| NCT03704714 | Nivolumab and Combination Chemotherapy in Treating Participants With Diffuse Large B-Cell Lymphoma | suspended | Phase 1 / Phase 2 | 30 | Northwestern UniversityOTHER | 1 | Aug 15, 2022 | clinicaltrials |
| NCT03322813 | ExAblate Blood Brain Barrier Disruption (BBBD) for Planned Surgery in Suspected Infiltrating Glioma | suspended | N/A | 15 | InSightecINDUSTRY | 1 | Aug 3, 2022 | clinicaltrials |
| NCT01982175 | Phase II Clinical Trial of Alemtuzumab to Treat B-cell Chronic Lymphocytic Leukemia(CLL004) | suspended | Phase 2 | 120 | Shanghai Zhangjiang Biotechnology Limited CompanyINDUSTRY | 1 | Jun 21, 2022 | clinicaltrials |
| NCT03752541 | Efficacy and Safety Evaluation of BCMA-UCART | suspended | N/A | 20 | Bioray LaboratoriesINDUSTRY | 1 | May 20, 2022 | clinicaltrials |
| NCT00474331 | Gene Mutations and Orthopaedic Symptoms Correlation of Multiple Hereditary Exostoses: Multicentre Project | suspended | — | 2,000 | University of British ColumbiaOTHER | 1 | May 18, 2022 | clinicaltrials |
| NCT04219475 | Predicting Response Patterns to Treatment in Glioblastoma (GBM) Patients(PROPHETIC) | suspended | — | 1,000 | OncoHost Ltd.INDUSTRY | 1 | Apr 19, 2022 | clinicaltrials |
| NCT02924714 | SSG XXV: The Stop-GIST Trial; Discontinuation of Imatinib in Patients With Oligo-metastatic GIST | suspended | N/A | 31 | Oslo University HospitalOTHER | 1 | Feb 18, 2022 | clinicaltrials |
| NCT04506983 | GPC3-CAR-T Cells for the Hepatocellular Carcinoma | suspended | Phase 1 | 12 | Beijing Tsinghua Chang Gung HospitalOTHER | 1 | Feb 14, 2022 | clinicaltrials |
| NCT04697290 | CD19/CD20 Dual-CAR-T in B-cell Non-Hodgkin's Lymphoma Patients. | suspended | Early Phase 1 | 12 | Beijing Tsinghua Chang Gung HospitalOTHER | 1 | Feb 14, 2022 | clinicaltrials |
| NCT03945786 | Diagnostic Performance of Hybrid PET/MRI in the Staging of Endometrial Carcinoma | suspended | — | 120 | Xuanwu Hospital, BeijingOTHER | 1 | Dec 6, 2021 | clinicaltrials |
| NCT02910752 | CLAM Chemotherapy With PBSC Support for Relapsed Patients After Allogeneic Stem Cell Transplantation | suspended | Phase 1 / Phase 2 | 20 | Shanghai Jiao Tong University School of MedicineOTHER | 1 | Nov 26, 2021 | clinicaltrials |
| NCT04250818 | Predicting Response of Metastatic Triple Negative Breast Cancer to Immunotherapy Based on Patients Cytokine Profile | suspended | — | 20 | Texas Tech University Health Sciences Center, El PasoOTHER | 1 | May 19, 2021 | clinicaltrials |
| NCT04835025 | Radiotherapy Combined With Immunotherapy for Brain Metastases of Non-small Cell Lung Cancer | suspended | — | 200 | Tongji HospitalOTHER | 1 | Apr 8, 2021 | clinicaltrials |
| NCT03722186 | Safety, Tolerability and Pharmacokinetics/Pharmacodynamics (PK/PD) of SHR-1603 in Subjects With Advanced Malignancies | suspended | Phase 1 | 128 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Mar 22, 2021 | clinicaltrials |
| NCT04084158 | A Study of Toripalimab Combined With Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma. | suspended | Phase 2 | 100 | Zhejiang Cancer HospitalOTHER | 1 | Feb 23, 2021 | clinicaltrials |
| NCT03839277 | Adenoma Detection Rate Using Endocuff Vision in China(SinoEVADR) | suspended | N/A | 1,200 | Changhai HospitalOTHER | 1 | Sep 28, 2020 | clinicaltrials |
| NCT03990974 | Postoperative Antimicrobial Prophylaxis Versus Placebo for Infection Prevention in HCC After Liver Resection(HCC) | suspended | Phase 3 | 458 | Sun Yat-sen UniversityOTHER | 1 | Mar 25, 2020 | clinicaltrials |
| NCT02356991 | A Study of Famitinib in Patients With Advanced Non-squamous and Non-Small Cell Lung Cancer (NSCLC) | suspended | Phase 2 | 137 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Nov 4, 2019 | clinicaltrials |
| NCT03777579 | A Study of First-line JS001 and Nab-paclitaxel Versus Palcelbo and Nab-Paclitaxel in Participants With Advanced Recurrent or Metastatic TNBC | suspended | Phase 3 | 375 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd.INDUSTRY | 1 | Aug 8, 2019 | clinicaltrials |
| NCT01988831 | Efficacy of Propranolol Treatment to Prevent Melanoma Progression | suspended | Phase 2 | 450 | University Hospital, GenevaOTHER | 1 | May 10, 2019 | clinicaltrials |
| NCT01974479 | Pilot Study of Redirected Haploidentical Natural Killer Cell Infusions for B-Lineage Acute Lymphoblastic Leukemia | suspended | Phase 1 | 20 | National University Health System, SingaporeOTHER | 1 | Apr 12, 2019 | clinicaltrials |
| NCT03779100 | Lenvatinib Plus PD-1 Antibody for Unresectable ICC | suspended | Phase 2 | 25 | Shi MingOTHER | 1 | Jan 28, 2019 | clinicaltrials |
| NCT01755325 | Phase III Study of Compound Formula Realgar-Indigo Naturalis Plus Imatinib Versus Placebo Plus Imatinib in Adult CML-CP Patients With Ph+ | suspended | Phase 3 | 680 | Junmin LiOTHER | 1 | Apr 25, 2018 | clinicaltrials |
| NCT01627795 | Safety and Efficacy of Oshadi D and Oshadi R for Malignant Mesothelioma Treatment | suspended | Phase 1 / Phase 2 | 17 | Oshadi Drug AdministrationINDUSTRY | 1 | Apr 18, 2018 | clinicaltrials |
| NCT02462265 | Oshadi D & Oshadi R Combined With Salvage Chemotherapy for Relapsed Acute Myeloid Leukemia or Lymphoid Leukemia Patients | suspended | Phase 2 | 15 | Oshadi Drug AdministrationINDUSTRY | 0 | Apr 18, 2018 | clinicaltrials |
| NCT02022293 | Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid Stenosis | suspended | Phase 2 | 324 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Dec 4, 2017 | clinicaltrials |
| NCT02026362 | Multiple Antigen Specific Cell Therapy (MASCT) for Hepatocellular Carcinoma(HCC) Patients After Radical Resection or Radio Frequency Ablation(RFA).(HCC DC CTL) | suspended | Phase 1 / Phase 2 | 100 | HRYZ Biotech Co.INDUSTRY | 1 | Oct 18, 2017 | clinicaltrials |
| NCT02008019 | A Phase II Study of EVEROLIMUS in Patients With Primary or Relapsed Chondrosarcomas(CHONRAD) | suspended | Phase 2 | 57 | Centre Leon BerardOTHER | 1 | Aug 7, 2017 | clinicaltrials |
| NCT02223975 | Evaluation of the Role of Vibrational Spectroscopy in the Assessment of Vulval Disease(Vulval VS) | suspended | — | 200 | Gloucestershire Hospitals NHS Foundation TrustOTHER | 1 | Aug 4, 2017 | clinicaltrials |
| NCT02742428 | Preoperative Ascites Drainage Versus Standard Care for Patients With Advanced Ovarian Cancer | suspended | N/A | 40 | Gdynia Oncology CenterOTHER_GOV | 1 | May 2, 2017 | clinicaltrials |
| NCT01709396 | ED-TBI Followed By Allogeneic Stem Cell Transplantation For The Treatment Of Refractory AML And Advanced MDS(ED-TBI) | suspended | Phase 2 | 20 | Ottawa Hospital Research InstituteOTHER | 1 | Jan 12, 2017 | clinicaltrials |
| NCT01342653 | Clinical Trial at Neoadjuvant Peritoneal and Systemic Chemotherapy Plus HIPEC in Gastric Carcinomatosis(HIPEC) | suspended | Phase 2 | 50 | Hospital General Universitario Gregorio MarañonOTHER | 1 | Nov 21, 2016 | clinicaltrials |
| NCT00892346 | Single Autologous Stem Cell Transplantation Followed by Maintenance Therapy as Front-line Treatment for Myeloma | suspended | Phase 3 | 80 | Shanghai Jiao Tong University School of MedicineOTHER | 1 | May 10, 2016 | clinicaltrials |
| NCT02470065 | Neoadjuvant Afatinib in Early Stage Non Small Cell Lung Cancer.(REMNANT) | suspended | Phase 2 | 38 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 0 | Jan 22, 2016 | clinicaltrials |
| NCT00986284 | Epidermal Growth Factor Receptor (EGFR) Status Based Gefitinib Neoadjuvant Therapy in Non Small Cell Lung Cancer (NSCLC) | suspended | Phase 2 | 102 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Dec 22, 2015 | clinicaltrials |
| NCT01211691 | Study of KB004 in Subjects With Hematologic Malignancies (Myelodysplastic Syndrome, MDS, Myelofibrosis, MF) | suspended | Phase 1 / Phase 2 | 120 | Humanigen, Inc.INDUSTRY | 2 | Nov 17, 2015 | clinicaltrials |
| NCT01720901 | Increased Dose of Icotinib in Advanced None Small Cell Lung Cancer Patients After Routine Gefitinib Therapy | suspended | Phase 4 | 20 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | May 22, 2015 | clinicaltrials |
| NCT02156180 | Identification of Breath Biomarkers in Head and Neck Squamous Cell Carcinoma | suspended | — | 13 | Queensland Centre of Excellence for Head and Neck CancerOTHER | 1 | Apr 22, 2015 | clinicaltrials |
| NCT01010373 | Safety and Efficacy Study of AS101 to Treat Elderly Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Patients | suspended | Phase 2 | 12 | BioMAS LtdINDUSTRY | 1 | Feb 10, 2015 | clinicaltrials |
| NCT01921998 | Development of a Biomarker Directed Strategy to Ameliorate Common Toxicities From Conventional Chemotherapy(BioACT) | suspended | — | 50 | The Christie NHS Foundation TrustOTHER | 1 | Feb 4, 2015 | clinicaltrials |
Data updated 22 days agoSource updated Oct 23, 2023source: clinicaltrials